ArticleFrontiers in pharmacology2024

Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic gastric mixed neuroendocrine-non-neuroendocrine tumor: a case report.

Lingnan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.